T2 Biosystems Initiates Studies to Add Acinetobacter Baumannii to the FDA-Cleared T2Bacteria Panel

20.10.2022 - LEXINGTON, Mass., Oct. 20, 2022 (GLOBE NEWSWIRE) - T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today that it has initiated studies to expand the number ... Seite 1

Related Keywords

John Sperzel ,Acinetobacter Baumannii ,Cauris Panel ,Biosystems Inc ,Bacteria Panel ,Nasdaq ,Lyme Panel ,Candida Panel ,Biothreat Panel ,Resistance Panel ,Initiates Studies ,Add Acinetobacter Baumannii ,